As of May 26
| -0.0099 / -1.74%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a +1,060.71% increase from the last price of 0.56.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.